Lau, Leyre Pernaute 
; Camara, Mahamadou ; Sousa, Taís Nóbrega de; Morris, Ulrika ; Ferreira, Marcelo Urbano ; Gil, José Pedro
Fonte: Expert Opinion on Drug Metabolism & Toxicology. Unidade: ICB
Assuntos: MICROBIOLOGIA, FARMACOGENÉTICA, MEDICAMENTO, ANTIMALÁRICOS, MALÁRIA FALCIPARUM, PLASMODIUM FALCIPARUM, MALÁRIA, RESISTÊNCIA MICROBIANA ÀS DROGAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAU, Leyre Pernaute et al. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology, v. 18, n. 1, p. 39-59, 2022Tradução . . Disponível em: https://doi.org/10.1080/17425255.2022.2049235. Acesso em: 29 set. 2024.APA
Lau, L. P., Camara, M., Sousa, T. N. de, Morris, U., Ferreira, M. U., & Gil, J. P. (2022). An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology, 18( 1), 39-59. doi:10.1080/17425255.2022.2049235NLM
Lau LP, Camara M, Sousa TN de, Morris U, Ferreira MU, Gil JP. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2022 ; 18( 1): 39-59.[citado 2024 set. 29 ] Available from: https://doi.org/10.1080/17425255.2022.2049235Vancouver
Lau LP, Camara M, Sousa TN de, Morris U, Ferreira MU, Gil JP. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2022 ; 18( 1): 39-59.[citado 2024 set. 29 ] Available from: https://doi.org/10.1080/17425255.2022.2049235
